SCHEMBL16275129

SCHEMBL16275129

O=c1ccc(-c2ccc(OCCCN3CCOCC3)cc2)cn1Cc1ccc(Cl)cc1F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 3/20 0.48
▸ HRH3 Q9Y5N1 10/20 0.47
▸ HRH2 P25021 1/20 0.47
▸ HRH1 P35367 1/20 0.47
▸ MAPK1 P28482 2/20 0.45
▸ SIGMAR1 Q99720 2/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CHRM2 P08172 1/20 0.45
▸ CHRM1 P11229 1/20 0.45
▸ HTR2A P28223 1/20 0.45
▸ SCN1A P35498 1/20 0.45
▸ HTR2B P41595 1/20 0.45
▸ KCNH2 Q12809 1/20 0.45
▸ SCN2A Q99250 1/20 0.45
▸ SCN3A Q9NY46 1/20 0.45
▸ USP2 O75604 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ ACHE P22303 1/20 0.44
▸ FLT3 P36888 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5439439 0.99 EPHX2 (0.47) EPHX2HRH3HRH2HRH1MAPK1
SCHEMBL5444759 0.95 ACHE (0.48) EPHX2HRH3HRH2HRH1ALDH1A1
SCHEMBL5439478 0.84 MAPT (0.45) HRH3HRH2HRH1CYP1A2HTR2A
SCHEMBL5194991 0.83 MAPT (0.46) HRH3CYP1A2HTR2A
SCHEMBL5439520 0.83 MAPT (0.46) HRH3
SCHEMBL5439446 0.81 MAPT (0.44) HRH3ALDH1A1CYP1A2HTR2A
SCHEMBL5438385 0.81 MAPK14 (0.45) HRH3ALDH1A1CYP1A2ACHEPSEN1
SCHEMBL5450888 0.81 CCNC (0.41) HRH3
SCHEMBL8264094 0.80 MAPT (0.47) HRH3ALDH1A1HTR2A
SCHEMBL5445008 0.80 MAPT (0.43) HRH3ALDH1A1CYP1A2ACHEPSEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1799646-B1 NOVEL PYRIDINONE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2-RECEPTORS JANSSEN PHARMACEUTICALS INC (US) 2014-12-10 — — EP claimed
Send feedback